OBJECTIVEdTo examine the association between genetic predisposition to type 2 diabetes (T2D) and risk of cardiovascular disease (CVD) among patients with T2D.
I
t has been postulated that type 2 diabetes (T2D) and cardiovascular disease (CVD) might spring from a "common soil" where both conditions share common genetic and environmental antecedents (1) . Identification of the shared genetic risk factors may improve our understanding of the etiological link of these two diseases. A recent study reported a significant association between a genetic score based on multiple diabetes-predisposing variants and increased risk of coronary heart disease (CHD) in a general population (2) . In this study, we constructed a genetic predisposition score (GPS) on the basis of 36 established T2D-predisposing variants, and examined its association with cardiovascular complications among people with T2D.
RESEARCH DESIGN AND METHODS

Study population
The Nurses' Health Study (NHS) is a prospective cohort study of 121,700 female registered nurses who were 30-55 years old starting in 1976 (3). The Health Professionals Follow-up Study (HPFS) is a prospective cohort study of 51,529 male health professionals who were 40-75 years old starting in 1986 (4). For the current analysis, NHS and HPFS participants were T2D cases who had genotype data from the T2D genome-wide association scans (5) . T2D cases were diagnosed during follow-up through 2006. CVD cases were defined as CHD (fatal or nonfatal myocardial infarction, coronary artery bypass grafting, or percutaneous transluminal coronary angioplasty) or stroke (fatal or nonfatal) (6 ). Blood samples were collected in 1990 and 1994 for women and men, respectively. Measurements of hemoglobin A 1c (HbA 1c ), triglycerides, total and HDL cholesterols, adiponectin, and C-reactive protein have been described elsewhere (7).
Genotyping and GPS calculation
We selected 36 single nucleotide polymorphisms (SNPs) associated with T2D at a genome-wide significance level in Caucasians (8, 9) . SNP genotyping and imputation have been described elsewhere (5) . For each individual, we summed the number of risk alleles of the SNPs to produce a GPS (10) . Most of the SNPs included in the GPS were genotyped or had a high imputation quality score (Supplementary Table 1 ).
Statistical analyses
We used logistic regression to estimate odds ratios (ORs) and 95% CI for CVD risk. General linear regression models were applied to test associations between the GPS and biochemical markers. The results in men and women were combined by inverse variance-weighted, fixed-effects meta-analysis. Statistical analyses were performed in SAS 9.1 (SAS Institute, Cary, NC).
RESULTSdCharacteristics of participants are shown in Supplementary Table  2 . The GPS showed consistent associations with CVD in men and women, with a combined OR per diabetes risk allele of 1.03 (95% CI 1.00-1.05). The OR for CVD was 1.40 (1.06-1.84) by comparing extreme quartiles of the GPS (P for trend = 0.03) ( Table 1 ). There was a linear relationship between the GPS and CVD risk (Supplementary Fig. 1 ). Results were similar when the outcome was restricted to CHD (excluding stroke cases).
We further examined the associations between the GPS and biochemical risk factors in a subgroup of diabetic patients (Supplementary Table 3 CONCLUSIONSdOur data indicate that the genetic predisposition to T2D may increase CVD risk among people with T2D. This suggests that CVD may partly share the genetic predisposition with T2D, supporting the "common soil" hypothesis at a genetic level (1) . Several studies have examined the associations between the individual diabetespredisposing genetic variants and CVD risk and yield inconsistent results (11) (12) (13) (14) . In the current study, most individual SNPs were not significantly associated with CVD risk (Supplementary Table 4 ). This was not surprising because these SNPs individually only explain a very small proportion of the variation in T2D risk. Thus, we estimated the overall genetic susceptibility to T2D by computing a GPS on the basis of 36 well-established diabetes-predisposing variants. Consistently, Pfister et al. (2) also found that a diabetes genetic score was significantly associated with increased CHD risk in a general population.
We observed that the GPS was positively associated with HbA 1c , a marker reflecting severity of hyperglycemia. The association for CVD risk was attenuated after adjustment for HbA 1c . These findings suggest that the GPS might reflect the severity of hyperglycemia, which may partly account for the observed genetic association for CVD risk. Consistently, epidemiological studies have shown that poor glycemic control was associated with increased CVD risk among diabetic patients (15) . Because HbA 1c levels were not measured at baseline and only a subgroup of the participants had data on this marker, we were limited to perform more analysis to test potential mechanisms underlying the observed associations. In addition, the covariates were assessed in participants either before or after the diagnosis of T2D. However, the observed genetic associations were less likely to be affected since genetic variants are randomly assigned and generally uncorrelated with the covariates.
In conclusion, we found that the genetic predisposition to T2D was significantly associated with an increased risk of CVD in patients with T2D. Further studies are needed to examine the relationship among the genetic predisposition to T2D, glycemic control, and CVD. ) , smoking (never, past, or current), alcohol intake (0, 0.1-4.9, 5.0-9.9, 10.0-14.9, or $15.0 g/day), physical activity (quintiles), and menopausal status (pre-or postmenopausal [never, past, or current hormone use], women only). †Results were combined between women and men using inverse variance weights under fixed model, as there was no detectable heterogeneity between women and men (all P for heterogeneity .0.57).
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